Nucleoside analogues achieve high concentrations in seminal plasma: Relationship between drug concentration and virus burden

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 2039-2043

  Pereira, Arlene S ^a   Kashuba, Angela D M ^b   Fiscus, Susan A ^a   Hall, James E ^a   Tidwell, Richard R ^a   Troiani, Luigi ^a   Dunn, John A ^c   Eron Jr , Joseph J ^a   Cohen, Myron S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; DRUG BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE; NONHUMAN; PRIORITY JOURNAL; SEMINAL PLASMA; SEXUAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; RNA, VIRAL; SEMEN; VIRAL LOAD; ZIDOVUDINE;

EID: 0343630779     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315149     Document Type: Article

References (16)

1. 1. Royce RA, Sofia A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
2. 2. Lee TH, Sakahara N, Fiebig E, Busch MP, O'Brien TR, Herman SA. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:427-8.
3. 3. Ragni MV, Faruki H, Kingsley LA. Heterosexual HIV-1 transmission and viral load in hemophiliac patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:42-5.
4. 4. Vernazza PL, Eron JJ, Cohen MS, van der Horst CM, Troiani L, Fiscus SA. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994;8:1325-9.
5. 5. Coombs RW, Speck CE, Hughes JP, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1 ) in semen and HIV-1 RNA levels in semen and blood evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998;177:320-30.
6. 6. Kashuba ADM, Dyer JR, Kramer LM, Raasch RH, Eron JJ, Cohen MS. Antiretroviral drug concentrations in semen: implications for sexual transmission of HIV-1. Antimicrob Agents Chemother 1999;43:1817-26.
7. 7. Henry K, Chinnock BJ, Quinn RP, Fletcher CV, de Miranda P, Balfour HH Jr. Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS related complex. JAMA 1988;259:3023-6.
8. 8. Taylor S, Back DJ, Workman J, Drake SM, White DJ, Choudhury B, Cane PA, et al. Poor penetration of the male genial tract by HIV-1 protease inhibitors. AIDS 1998;13(7):859-60.
9. 9. Dyer JR, Gilliam BL, Eron JJ Jr, Grosso L, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription PCR amplification and correlation with quantitative culture. J Virol Methods 1996;60:161-70.
10. 10. Gilliam BL, Dyer JR, Fiscus SA, et al. Effect of reverse transcriptase inhibitor therapy on HIV1 viral burden in semen. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:54-60.
11. 11. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriplase inhibitors. J Virol 1997;71:6271-5.
12. 12. Vernazza PL, Gilliam BL, Flepp M, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997;11:1249-54.
13. 13. Mayer KH, Boswell S, Goldstein R, et al. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 1999;28:1252-9.
14. 14. DePasquale MP, Rosenberg E. Quayle A, et al. Primary HIV infection: in vivo fitness of pre-therapy resistant mutants and potential for secondary spread of HIV from semen [abstract 126]. In: Proceedings of the 3d International Workshop on HIV Drug Resistance and Treatment Strategies. San Diego, 23 26 June 1999.
15. 15. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency antiretroviral therapy. N Engl J Med 1998;339:1803-9.
16. 16. Musicco M, Lazzarin A, Nicolosi A, Gasparini M, Costigliola P, Arici C, for the Italian Study Group on HIV Heterosexual Transmission. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med 1994;154:1971-6.